Product Description: Mc-MMAD is a protective group (maleimidocaproyl)-conjugated MMAD. MMAD is a potent tubulin inhibitor. Mc-MMAD is a agent-linker conjugate for ADC.
Applications: Cancer-programmed cell death
Formula: C51H77N7O9S
References: [1]Antibody-drug conjugates Patent: WO 2013068874 A1
CAS Number: 1401963-15-2
Molecular Weight: 964.26
Compound Purity: 98.50
Research Area: Cancer
Solubility: DMSO : ≥ 100 mg/mL
Target: Drug-Linker Conjugates for ADC;Microtubule/Tubulin